Probiotics (behavior)

The gut-brain axis (GBA) is a sophisticated, bidirectional signaling network that integrates the biochemical activities of the gastrointestinal tract with the central nervous system (CNS). The intestinal microbiome plays a fundamental role in maintaining this axis(Sacoor et al., 2024). Under physiological conditions, these microbes assist in neurodevelopment and the regulation of the blood-brain barrier. However, when the microbial ecosystem experiences dysbiosis, the resulting imbalance can compromise the intestinal lining. This "leaky gut" allows proinflammatory compounds and bacterial metabolites to enter the bloodstream, potentially leading to neuroinflammation and the disruption of neural circuits associated with mood and behavior.

The pathophysiology of behavioral disorders can occasionally be linked to the microbiome’s ability to synthesize and modulate neuroactive compounds. Specific bacteria are capable of producing essential neurotransmitters such as serotonin (5-HT), dopamine, and gamma-aminobutyric acid (GABA), which are critical for emotional regulation and cognitive function. For example, a significant portion of the body's serotonin is synthesized in the gut, and its availability is heavily influenced by microbial metabolism. Preliminary investigations in fearful companion dogs have documented significant alterations in molecules associated with GABA and glutamate neurotransmission, as well as bile acid metabolism, highlighting the role of the microbiome-metabolome network in canine behavior(Sacchettino et al., 2025). When these microbial signals are skewed, they can cause a chronic overactivation of the HPA axis, resulting in elevated cortisol levels and a heightened state of physiological stress.

To mitigate these disruptions, probiotic supplementation is posited as a potential strategy to modulate the GBA and improve behavioral disorders. Probiotics, particularly those categorized as psychobiotics, work by restoring microbial diversity and reinforcing the gut’s epithelial barrier, thereby reducing systemic inflammation. Specific strains, such as Lactiplantibacillus plantarum (LP815™), have shown significant improvements in aggression and anxiety scores, supported by objective data such as faster post-departure settling and improved sleep consistency(Bijaoui & Zimmerman, 2025). Similarly, Bifidobacterium longum (BL999) has been associated with significant reductions in anxious behaviors like barking, jumping, and spinning, as well as reduced salivary cortisol and improved heart rate variability(McGowan et al., 2018). These beneficial bacteria produce short-chain fatty acids (SCFAs) like butyrate, which possess neuroprotective properties and help regulate gene expression within the brain. By strategically reintroducing these strains, it may be possible to "re-tune" the communication between the gut and the brain, offering a biological pathway to stabilize emotional and behavioral phenotypes.

This realm of medicine is in the early stages of research in veterinary medicine (as well as human medicine). Many unknowns exist, including the effects of various probiotic strains (including dose-dependent effects) for specific conditions(Sacoor et al., 2024).